Advertisement

Here's What the Market Got Wrong About Teladoc's Earnings

When Teladoc Health (NYSE: TDOC) announced its financial results late last month, the results were eye-popping. Excluding one-time charges, Teladoc cut is net loss by half. In this Earnings Review that aired on Fool Live on Oct. 30, Fool.com contributors Danny Vena, Daniel Sparks, and Jason Hall discuss the market's reaction to Teladoc's earnings and the close of its merger with Livongo Health -- and why the market got it wrong.